Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda
Status:
Withdrawn
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The effectiveness of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment in
pregnancy in malaria-endemic areas the effectiveness and efficacy of SP may be compromised by
increased SP resistance. This study will evaluate the efficacy of SP by giving SP to
asymptomatic parasitemic pregnant women and following them to determine the rates of parasite
clearance.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Centers for Disease Control and Prevention Uganda Malaria Surveillance Project
Treatments:
Fanasil, pyrimethamine drug combination Pyrimethamine Sulfadoxine